TYK2 and cancer: Notably, this study solely genotyped the somatic cancer cells and overlooked that this mutation impairs TYK2 catalytic activity; cellular signaling, however, is not completely abrogated, and the detected induction of BCL2 expression might favor an anti-apoptotic program [69,70].